Q4 2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Leerink Swann

Q4 2017 EPS Estimates for Edwards Lifesciences Corporation (EW) Decreased by Leerink Swann


Edwards Lifesciences Corporation - Analysts at Leerink Swann reduced their Q4 2017 EPS estimates for shares of Edwards Lifesciences Corporation in a research note issued to investors on Thursday. Leerink Swann analyst D. Antalffy now expects that the medical research company will earn $0.88 per share for the quarter, down from their previous forecast of $0.89.



from Biotech News